Gallery of new files
Jump to navigation
Jump to search
This special page shows the last uploaded files.
-
Finerenone Table 4 Clinical Studies.png Tejasvi Aryaputra
00:16, 6 September 2022
608 × 1,450; 175 KB
-
Finerenone Table 3 Adverse Reactions.png Tejasvi Aryaputra
00:15, 6 September 2022
1,004 × 656; 85 KB
-
Finerenone Table 2 Dosage Adjustments.png Tejasvi Aryaputra
00:15, 6 September 2022
1,142 × 898; 147 KB
-
Finerenone Figure 2 Clinical Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,290 × 1,080; 519 KB
-
Finerenone Figure 1 Clincal Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,326 × 1,158; 550 KB
-
Fexinidazole Table 5 Pharmocokinetics.png Tejasvi Aryaputra
02:11, 5 September 2022
640 × 1,514; 262 KB
-
Fexinidazole Table 4 Drug Interactions Pt.4.png Tejasvi Aryaputra
02:10, 5 September 2022
622 × 658; 133 KB
-
Fexinidazole Table 3 Drug Interactions Pt.1.png Tejasvi Aryaputra
02:10, 5 September 2022
612 × 1,028; 209 KB
-
Fexinidazole Table 2 Adverse Reactions Pt.2.png Tejasvi Aryaputra
02:10, 5 September 2022
610 × 546; 78 KB
-
Fexinidazole Table 2 Adverse Reactions.png Tejasvi Aryaputra
02:10, 5 September 2022
622 × 1,308; 188 KB
-
Belumosudil Table 2 Adverse Reactions.png Tejasvi Aryaputra
01:34, 30 August 2022
586 × 1,246; 135 KB
-
Belumosudil Table 2 Adverse Reactions Pt. 2.png Tejasvi Aryaputra
01:32, 30 August 2022
540 × 676; 136 KB
-
Odevixibat Table 3 Adverse Reactions.png Tejasvi Aryaputra
00:38, 25 August 2022
1,270 × 1,274; 218 KB
-
Odevixibat Package Label (1200 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,344 × 1,320; 470 KB
-
Odevixibat Package Label (600 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,348 × 1,448; 509 KB
-
Odevixibat Package Label (400 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,340 × 1,320; 471 KB
-
Odevixibat Package Label (200 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,344 × 1,446; 486 KB
-
•Prodrome weakness, malaise, myalgias, abdominal pain.png Hassan M
04:22, 7 August 2022
1,024 × 768; 106 KB
-
Anifrolumab-fnia Table 1 Adverse Reactions.png Tejasvi Aryaputra
18:22, 5 August 2022
1,312 × 1,370; 197 KB
-
Small-cell-lung-cancer-right-upper-lobe-collapse.jpg Hassan M
18:56, 31 July 2022
1,600 × 1,600; 245 KB
-
Avalglucosidase alfa-ngpt Table 5 Walking.png Tejasvi Aryaputra
18:51, 25 July 2022
1,216 × 970; 193 KB
-
Avalglucosidase alfa-ngpt Table 4 FVC.png Tejasvi Aryaputra
18:51, 25 July 2022
1,202 × 1,024; 208 KB
-
Avalglucosidase alfa-ngpt Table 3 Antibodies.png Tejasvi Aryaputra
18:50, 25 July 2022
612 × 856; 141 KB
-
Avalglucosidase alfa-ngpt Table 2 Adverse Reactions.png Tejasvi Aryaputra
18:50, 25 July 2022
1,204 × 1,162; 183 KB
-
Avalglucosidase alfa-ngpt Table 1 Infusion Rate.png Tejasvi Aryaputra
18:50, 25 July 2022
1,240 × 902; 134 KB
-
Avalglucosidase alfa-ngpt Packaging Label 2.png Tejasvi Aryaputra
18:50, 25 July 2022
646 × 156; 25 KB
-
Avalglucosidase alfa-ngpt Packaging Label.png Tejasvi Aryaputra
18:50, 25 July 2022
656 × 1,484; 230 KB
-
Avalglucosidase alfa-ngpt Figure 2 Walking.png Tejasvi Aryaputra
18:50, 25 July 2022
1,274 × 816; 238 KB
-
Avalglucosidase alfa-ngpt Figure 1 FVC.png Tejasvi Aryaputra
18:49, 25 July 2022
1,288 × 842; 241 KB
-
Avalglucosidase alfa-ngpt Drug Packaging.png Tejasvi Aryaputra
18:49, 25 July 2022
1,334 × 1,410; 713 KB
-
Belzutifan Table 3 Lab Abnormalities.png Tejasvi Aryaputra
18:55, 21 July 2022
1,192 × 1,210; 163 KB
-
Giemsa stain of bone marrow biopsy showing sheets of plasma cells..jpg Ariwoola Azeezat Oyetola
12:03, 21 July 2022
960 × 720; 191 KB
-
Difelikefalin Table 2 Adverse Reactions.png Tejasvi Aryaputra
20:14, 12 July 2022
1,328 × 1,196; 189 KB
-
Lonapegsomatropin-tcgd Table 6 Catridges.png Tejasvi Aryaputra
12:36, 5 July 2022
1,126 × 818; 92 KB
-
Lonapegsomatropin-tcgd Table 5 Height SDS.png Tejasvi Aryaputra
12:36, 5 July 2022
1,208 × 750; 128 KB
-
Lonapegsomatropin-tcgd Table 4 High Velocity.png Tejasvi Aryaputra
12:36, 5 July 2022
1,192 × 834; 163 KB
-
Lonapegsomatropin-tcgd Table 3 Drug Interactions.png Tejasvi Aryaputra
12:36, 5 July 2022
614 × 1,262; 255 KB
-
Lonapegsomatropin-tcgd Table 2 Adverse Reactions.png Tejasvi Aryaputra
12:35, 5 July 2022
1,272 × 1,132; 207 KB
-
Lonapegsomatropin-tcgd Drug Label 13.3 Mg Pt.2.png Tejasvi Aryaputra
12:35, 5 July 2022
1,326 × 1,168; 602 KB
-
Lonapegsomatropin-tcgd Drug Label 13.3 Mg Pt.1.png Tejasvi Aryaputra
12:35, 5 July 2022
1,298 × 712; 341 KB
-
Lonapegsomatropin-tcgd Drug Label 11 Mg Pt.2.png Tejasvi Aryaputra
12:35, 5 July 2022
1,316 × 1,178; 603 KB
-
Lonapegsomatropin-tcgd Drug Label 11 Mg Pt.1.png Tejasvi Aryaputra
12:35, 5 July 2022
1,320 × 718; 340 KB
-
Lonapegsomatropin-tcgd Drug Label 9.1 Mg Pt.2.png Tejasvi Aryaputra
12:33, 5 July 2022
1,316 × 1,186; 604 KB
-
Lonapegsomatropin-tcgd Drug Label 9.1 Mg Pt.1.png Tejasvi Aryaputra
12:33, 5 July 2022
1,284 × 720; 341 KB
-
Lonapegsomatropin-tcgd Drug Label 7.6 Mg Pt.2.png Tejasvi Aryaputra
12:32, 5 July 2022
1,326 × 1,192; 560 KB
-
Lonapegsomatropin-tcgd Drug Label 7.6 Mg Pt.1.png Tejasvi Aryaputra
12:32, 5 July 2022
1,304 × 726; 345 KB
-
Lonapegsomatropin-tcgd Drug Label 6.3 Mg Pt.2.png Tejasvi Aryaputra
12:32, 5 July 2022
1,328 × 1,178; 556 KB
-
Lonapegsomatropin-tcgd Drug Label 6.3 Mg Pt.1.png Tejasvi Aryaputra
12:31, 5 July 2022
1,292 × 726; 339 KB
-
Lonapegsomatropin-tcgd Drug Label 5.2 Mg Pt.2.png Tejasvi Aryaputra
12:31, 5 July 2022
1,324 × 1,186; 554 KB
-
Lonapegsomatropin-tcgd Drug Label 5.2 Mg Pt.1.png Tejasvi Aryaputra
12:31, 5 July 2022
1,320 × 730; 341 KB
-
Lonapegsomatropin-tcgd Drug Label 4.3 Mg Pt.2.png Tejasvi Aryaputra
12:31, 5 July 2022
1,328 × 1,196; 560 KB
-
Lonapegsomatropin-tcgd Drug Label 4.3 Mg Pt.1.png Tejasvi Aryaputra
12:30, 5 July 2022
1,318 × 720; 337 KB
-
Lonapegsomatropin-tcgd Drug Label 3.6 Mg Pt.2.png Tejasvi Aryaputra
12:29, 5 July 2022
1,318 × 1,190; 560 KB
-
Lonapegsomatropin-tcgd Drug Label 3.6 Mg Pt.1.png Tejasvi Aryaputra
12:29, 5 July 2022
1,306 × 724; 338 KB
-
Lonapegsomatropin-tcgd Drug Label 3 Mg Pt.2.png Tejasvi Aryaputra
12:29, 5 July 2022
1,316 × 1,178; 554 KB
-
Lonapegsomatropin-tcgd Drug Label 3 Mg Pt.1.png Tejasvi Aryaputra
12:29, 5 July 2022
1,268 × 732; 338 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.6.png Tejasvi Aryaputra
12:29, 5 July 2022
654 × 492; 84 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.5.png Tejasvi Aryaputra
12:28, 5 July 2022
660 × 1,314; 243 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.4.png Tejasvi Aryaputra
12:28, 5 July 2022
666 × 1,418; 259 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.3.png Tejasvi Aryaputra
12:28, 5 July 2022
658 × 1,224; 215 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.2.png Tejasvi Aryaputra
12:28, 5 July 2022
664 × 1,318; 245 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.1.png Tejasvi Aryaputra
12:28, 5 July 2022
670 × 1,416; 259 KB
-
Mobocertinib Table 4 Adverse Reactions Lab Abnormalties.png Tejasvi Aryaputra
20:18, 15 June 2022
1,326 × 1,626; 270 KB
-
Mobocertinib Table 3 Adverse Reactions.png Tejasvi Aryaputra
20:18, 15 June 2022
660 × 1,268; 157 KB
-
Mobocertinib Table 2 Dosage for Adverse Reactions Pt.2.png Tejasvi Aryaputra
20:17, 15 June 2022
646 × 812; 122 KB
-
Mobocertinib Table 2 Dosage for Adverse Reactions.png Tejasvi Aryaputra
20:17, 15 June 2022
660 × 1,254; 215 KB
-
Acute Interstitial Pneumonitis Chest Xray - Case Courtesy of Dr Salam, Radiopaedia, rID 45404.jpeg Nnabude
04:32, 5 May 2022
630 × 586; 45 KB
-
Congenital-diaphragmatic-hernia-right-sided-1.jpg AroojNaz
08:18, 23 April 2022
1,631 × 1,129; 197 KB
-
Endometrial-polyp-with-complex-hyperplasia-and-atypia-pathology-2.jpg AroojNaz
11:29, 9 March 2022
2,520 × 1,899; 1.62 MB
-
Endometrial-polyp-with-complex-hyperplasia-and-atypia-pathology.jpg AroojNaz
11:28, 9 March 2022
1,716 × 1,914; 812 KB
-
Endometrial-carcinoma-in-premenopausal-woman.png AroojNaz
10:33, 9 March 2022
1,556 × 1,002; 1.42 MB
-
Tisotumab vedotin-tftv Packaging Label.png Tejasvi Aryaputra
02:29, 27 January 2022
640 × 1,324; 175 KB
-
Tisotumab vedotin-tftv Drug Packaging .png Tejasvi Aryaputra
02:28, 27 January 2022
1,322 × 1,316; 1,003 KB
-
Tisotumab vedotin-tftv Table 7 Efficacy.png Tejasvi Aryaputra
02:28, 27 January 2022
1,238 × 854; 109 KB
-
Tisotumab vedotin-tftv Table 6 Pharmacodynamics.png Tejasvi Aryaputra
02:28, 27 January 2022
976 × 452; 85 KB
-
Tisotumab vedotin-tftv Table 2 Adverse Reactions.png Tejasvi Aryaputra
02:27, 27 January 2022
662 × 1,458; 268 KB
-
Tisotumab vedotin-tftv Table 3 Storage.png Tejasvi Aryaputra
02:27, 27 January 2022
1,038 × 634; 101 KB
-
Tisotumab vedotin-tftv Table 5 Lab Data.png Tejasvi Aryaputra
02:26, 27 January 2022
640 × 916; 118 KB
-
Tisotumab vedotin-tftv Table 4 Adverse Reactions.png Tejasvi Aryaputra
02:26, 27 January 2022
656 × 1,488; 144 KB
-
Tisotumab vedotin-tftv Table 1 Dose Schedule.png Tejasvi Aryaputra
02:26, 27 January 2022
796 × 474; 59 KB
-
Atogepant Figure 4 Distribution of Baseline.png Tejasvi Aryaputra
23:18, 19 January 2022
1,300 × 766; 352 KB
-
Atogepant Table 4 Study 2 Efficacy .png Tejasvi Aryaputra
23:18, 19 January 2022
1,308 × 982; 148 KB
-
Atogepant Figure 2 Distribution Change.png Tejasvi Aryaputra
23:17, 19 January 2022
1,312 × 978; 540 KB
-
Atogepant Table 1 Dosage Modifications.png Tejasvi Aryaputra
23:11, 19 January 2022
1,180 × 696; 129 KB
-
Maralixibat Table 3 Clinical Trial Data.png Tejasvi Aryaputra
03:29, 17 January 2022
1,006 × 624; 101 KB
-
Maralixibat Table 2 Adverse Reactions.png Tejasvi Aryaputra
03:28, 17 January 2022
686 × 1,404; 330 KB
-
Avacopan Drug Packaging 30 Tablets.png Tejasvi Aryaputra
00:54, 11 January 2022
1,314 × 1,216; 621 KB
-
Avacopan Figure 1 Sustained Remission.png Tejasvi Aryaputra
00:49, 11 January 2022
1,324 × 1,454; 457 KB
-
Avacopan Table 4 Sustained Remission.png Tejasvi Aryaputra
00:49, 11 January 2022
1,282 × 824; 175 KB
-
Avacopan Table 3 Pharmacokinetcis Changes.png Tejasvi Aryaputra
00:48, 11 January 2022
1,288 × 758; 147 KB
-
Avacopan Table 2 Pharmacokinetics with M1.png Tejasvi Aryaputra
00:48, 11 January 2022
1,290 × 936; 174 KB
-
Avacopan Table 1 Adverse Reactions.png Tejasvi Aryaputra
00:38, 11 January 2022
1,272 × 1,244; 191 KB
-
Pneumococcal-pneumonia-complication-parapneumonic-effusion-1.png AroojNaz
10:58, 10 January 2022
512 × 512; 259 KB
-
Asciminib Table 5 Adverse Reactions .png Tejasvi Aryaputra
21:45, 5 January 2022
674 × 1,282; 219 KB
-
Pathophysiology of Non Suicidal Self Injury (2).jpg Sunita Kumawat
23:52, 11 August 2021
3,220 × 1,522; 464 KB
-
DSM-5 criteria for diagnosis of Non Suicidal Self Injury.PNG Sunita Kumawat
20:31, 8 August 2021
1,189 × 526; 302 KB
-
Dural-venous-sinus-thrombosis-secondary-to-otomastoiditis.jpg Sharmi Biswas
01:42, 3 August 2021
288 × 288; 6 KB
-
A-hypothetical-mechanism-by-which-depression-during-pregnancy-and-postpartum-may.png Sunita Kumawat
20:45, 2 August 2021
727 × 803; 27 KB
-
Situs-ambiguous-asplenia-syndrome-with-bilateral-right-sidedness CT.jpg Kalpana
17:51, 20 July 2021
512 × 512; 90 KB
-
Situs-ambiguous-asplenia-syndrome-with-bilateral-right-sidedness.jpg Kalpana
15:43, 20 July 2021
512 × 512; 92 KB
-
Pancreatic-calcifications-chronic-pancreatitis.jpg Haseeb
17:52, 15 July 2021
2,520 × 3,028; 1.08 MB
-
Apple-core-sign-of-colonic-cancer-1.jpg Sahar Memar Montazerin
17:46, 15 July 2021
1,492 × 1,419; 171 KB
-
1-s2.0-S1930043318300268-radcr487-fig-0003 lrg.jpg Sharmi Biswas
23:41, 19 June 2021
1,000 × 838; 155 KB
-
PERFUSE Clinical Trial Course - presentation of data.pptx Sahar Memar Montazerin
17:12, 8 June 2021
; 3.28 MB
-
Irispublishers-scientific-openaccess-research-reviews.ID.000505.G004.png Lina Alatta
00:04, 3 June 2021
458 × 379; 67 KB
-
PERFUSE Clinical Trial Course - Role of the PI.PPTX Sahar Memar Montazerin
17:25, 26 May 2021
; 1,006 KB
-
280px-Normal posteroanterior (PA) chest radiograph (X-ray).jpg Sharmi Biswas
19:09, 11 May 2021
280 × 320; 16 KB
-
PERFUSE Clinical Trial Course - Clinical Events Committee (CEC).pptx Sahar Memar Montazerin
13:00, 5 May 2021
; 257 KB
-
The Role of AROs In Clinical Research Don Cutlip April 2021.pptx Sahar Memar Montazerin
16:14, 22 April 2021
; 777 KB
-
Importance of Missing Data and Patient Retention by C Michael Gibson.pptx Sahar Memar Montazerin
00:03, 20 April 2021
; 139 KB
-
PERFUSE Clinical Trial Course GxP and Audits 09Apr2021.pptx Sahar Memar Montazerin
17:29, 9 April 2021
; 102 KB
-
Clinical Research Course Syllabus as of 4.9.21.pdf Sahar Memar Montazerin
17:24, 9 April 2021
; 549 KB
-
PERFUSE Clinical Trial Course Running a Clinical Trial Part 1.pptx Sahar Memar Montazerin
15:05, 30 March 2021
; 94 KB
-
Clinical Research Course Syllabus as of 3.29.21.pdf Sahar Memar Montazerin
21:32, 29 March 2021
; 550 KB
-
Intussusception-with-pseudokidney-and-target-sign-1.jpg Lina Alatta
01:45, 26 March 2021
705 × 613; 72 KB
-
Clinical Research Course Syllabus as of 3.18.21.pdf Sahar Memar Montazerin
19:53, 18 March 2021
; 548 KB
-
Clinical Research Course Syllabus as of 3.17.21.pdf Sahar Memar Montazerin
19:55, 17 March 2021
; 549 KB
-
PERFUSE Clinical Trial Course - Ethics Part 2.pptx Sahar Memar Montazerin
18:13, 16 March 2021
; 82 KB
-
Clinical Research Course Syllabus as of 3.9.21.pdf Sahar Memar Montazerin
22:54, 9 March 2021
; 170 KB
-
PERFUSE Clinical Trial Course - Ethics Part 1 Posted.pptx Sahar Memar Montazerin
22:52, 9 March 2021
; 143 KB
-
Clinical Research Course Syllabus as of 2.2.21.pdf Sahar Memar Montazerin
16:06, 2 February 2021
; 170 KB
-
Primary intestinal lymphangiectasia (Waldmann's disease) - legs.jpg Sara Mohsin
17:37, 21 January 2021
1,173 × 1,488; 521 KB
-
PERFUSE Clinical Trial Course - Protocol Amendments 1.19.21.pptx Sahar Memar Montazerin
20:49, 20 January 2021
; 199 KB
-
Intro to Observational Studies & Cohort 1.19.21.pptx Sahar Memar Montazerin
20:46, 20 January 2021
; 274 KB